A critical breakthrough in cancer research is occurring with the use of mini-antibodies to reactivate damaged p53. This vital tumor inhibitor protein is frequently disabled in various types of tumors, causing https://bookmarkpressure.com/story21858068/nanobodies-revive-the-p53-protein-the-promising-approach-for-cancer-treatment